Aurobindo Pharma reported INR9.21B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Cipla INR 7.89B 2.34B Jun/2026
Divis Laboratories Ltd INR 9.02B 1.51B Jun/2026
Dr.Reddys Laboratories INR 4.44B 2.23B Jun/2026
Hindustan Unilever INR 26.73B 3.19B Jun/2026
Sun Pharmaceuticals INR 28.95B 1.81B Jun/2026
UPL INR 80M 10.53B Jun/2026